Analyst firms · Leerink Partners · THC
Leerink Partners THC price target and rating history
Tenet Healthcare Corporation (THC) · Health Care
Leerink Partners rates Tenet Healthcare Corporation (THC) Outperform with a $100 price target, as of its latest action on Feb 9, 2022. It has published 4 rating actions on THC since September 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Outperform
- Price target
- $100
- Median target, all firms
- Too few
- Actions on THC
- 4
Leerink Partners price target on THC
Every Leerink Partners rating on THC
- Feb 9, 2022
- Jan 7, 2022
- Oct 22, 2021
- Sep 27, 2021
Questions about Leerink Partners and THC
- What is Leerink Partners's price target for THC?
- Leerink Partners's latest stated price target for Tenet Healthcare Corporation (THC) is $100, from its action on Feb 9, 2022.
- What is Leerink Partners's rating on THC?
- Leerink Partners rates THC Outperform, a bullish rating, as of Feb 9, 2022.
- When did Leerink Partners last change its view on THC?
- On Feb 9, 2022, Leerink Partners upgrades to Outperform from Market Perform, price target $88 to $100.
More THC rating histories
All Leerink Partners ratingsTHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.